It is estimated that up to 27% of autistic people experience anxiety and 23% develop depression, compared to 5.9% and 3.3% in the wider population.
Evidence-based psychological therapies, such as cognitive behavioural therapy or counselling, are recommended in by the National Institute for Health and Care Excellence (NICE) for autistic people who are struggling with their mental health. However, the researchers wanted to investigate whether the treatments currently available through the NHS are beneficial for the population of autistic people who require them.
The new study, published in Lancet Psychiatry, examined therapy outcomes for 8761 autistic adults who attended NHS Talking Therapies for Anxiety and Depression (formerly known as IAPT) Depressive symptoms were measured using the Patient Health Questionnaire (PHQ-9)**, which considers factors such as a lack of interest in doing things, issues with sleep, and feelings of low mood.
Symptoms of anxiety were measured using the GAD7 questionnaire, which asks how often a person feels worried, on edge or unable to relax.
Researchers used existing data from large medical records databases to measure participants’ outcomes (depression and anxiety scores) both before and after therapy to see if there was an improvement in symptoms.
The team found that, on average, autistic adults experienced a decrease in their anxiety and depression symptoms following a course of therapy. However, when these results were compared with the outcomes of nearly two million people who accessed the services but didn’t have a diagnosis of autism in their medical record, researchers found that the outcomes were poorer in the cohort of autistic people.
For example, autistic people were 25% less likely to see an improvement in their symptoms. They were also 34% more likely to experience a deterioration in symptoms of anxiety and depression, compared to people in the comparison group.
Lead author, PhD candidate Celine El Baou (UCL Psychology & Language Sciences) said: "Our analysis suggests that therapies offered in primary care may be beneficial for autistic people who experience depression, anxiety or both. However, we also found that not only were outcomes worse for autistic people following therapy, but the autistic population was largely under-represented in services. While the paper was unable to look at why this might be, we suspect it reflects the specific barriers that autistic people experience to access therapy and the lack of appropriate adaption for neurodiversity, including differences in thinking style, sensory sensitivities or the need for predictability."
Consequently, the team are now calling for mental healthcare
Ms El Baou, said: "It is important to note that our analysis has concentrated on those autistic people who have a diagnosis of autism in their medical records. This means that our study cannot tell us anything about therapy outcomes for the vast majority of autistic adults who do not have a formal diagnosis."
Anoushka Pattenden, Evidence and Research Manager (Partnerships) at the National Autistic Society, said: "We welcome UCL’s new study into the treatment of depression and anxiety experienced by autistic adults, and hope to see more studies in this under-researched area.
"The findings suggest that after treatment, autistic adults are less likely to show improvements for anxiety and depression than others; and may actually be more likely to experience a decline in their mental health. This reflects what we hear too often, that autistic adults are not getting the mental health support that they need.
"Action needs to be taken now to make sure health services are just as effective for autistic people. It’s vital that mental health professionals receive training in identifying and understanding autism, are flexible in their approach, and include autistic people in discussions about the treatment and adjustments they need.
"We continue to campaign for improved understanding, adapted support and better outcomes for autistic people to create the fair and equal health system they deserve.
Trends in underdiagnosis of autism may mean that the comparison group includes undiagnosed adults.
There is also no way for the study to establish the extent, if any, of adaptations made to clinical practice for autistic adults. Results rely on the assumption that outcomes established in the comparison group are also transferrable to autistic populations. However, while the PHQ-9 has been validated for use in autistic adults, the GAD-7 has not and recent research suggests that anxiety may present differently in autistic adults.
- University College London, Gower Street, London, WC1E 6BT (0) 20 7679 2000